Bulletin of Experimental Treatments for AIDS, No. 26 September 1995
Ronald Baker, PhD
Others disagree that AIDS research will suffer from the shift of budget authority away from OAR. Proponents of the subcommittee's new ruling say that placing AIDS research funding into the overall NIH budget has distinct advantages for AIDS research: one major advantage is to remove the budget as a "sitting duck target" for people who oppose AIDS research funding. If the funds are dispersed throughout the different institutes of NIH, it will be difficult or impossible to single out AIDS research dollars for close scrutiny and criticism.
As the new custodian of the AIDS research budget, NIH director Harold Varmus says he will carry out the recommendations of the Levine committee, a panel appointed by OAR to evaluate the NIH AIDS research budget. It is unclear at press time when the full House of representatives will vote on the NIH appropriation.
950901
BETA2630
Copyright © 1995 - Bulletin of Experimental Treatments for AIDS (BETA). Reproduced with permission. BETA is published four times a year by the San Francisco AIDS Foundation. All rights reserved. Noncommercial reproduction is encouraged. Subscription lists are kept confidential. Call 415.487.8060; FAX: 415.487.8069. Mailing Address: P.O. Box 426182, San Francisco, CA 94142-6182. beta@sfaf.org http://www.sfaf.org/beta.html